VIRIDIAN THERAPEUTICS
Viridian Therapeutics is a privately held biotechnology company focused on advancing new treatments for patients with diseases that are underserved by today’s therapies.
VIRIDIAN THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2019-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.viridianbio.com
Total Employee:
11+
Status:
Active
Contact:
919-949-8552
Total Funding:
29 M USD
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Modis Therapeutics
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Employees Featured
Founder
Official Site Inspections
http://www.viridianbio.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Viridian Therapeutics"
Viridian Biosciences - Crunchbase Investor Profile
Viridian is a biopharma incubator, founded to strengthen the link between scientific discovery and product commercialization. Viridian leverages validated scientific findings and a deep appreciation of evolving unmet needs to identify …See details»
www.viridianbio.com
Www.viridianbio.comSee details»
Viridian - Framing the future of autoimmune diseases
Viridian Therapeutics is leveraging core expertise in antibody discovery to develop optimized treatments for rare autoimmune conditionsSee details»
Viridian Therapeutics, Inc. - Investors & Media
Sep 11, 2024 · Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases.See details»
Viridian Therapeutics, Inc. | LinkedIn
Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases.See details»
Leadership - Viridian Therapeutics, Inc.
Tom Beetham joined Viridian as Chief Operating Officer in 2023. Tom has more than 20 years of experience in operations, business development, strategy and legal in the biopharmaceutical industry.See details»
Viridian Therapeutics, Inc. Information - RocketReach
Viridian Therapeutics, Inc. is a Biotechnology, Biotechnology Research, and Pharmaceuticals company located in Waltham, Massachusetts with $8 million in revenue and 162 employees. …See details»
Our Company - Viridian Therapeutics, Inc.
At Viridian Therapeutics, we are focused on developing best-in-class medicines for people living with autoimmune and rare diseases. Leveraging our team’s expertise in antibody discovery and engineering, we have created a robust …See details»
Viridian Therapeutics - MassBio
Viridian Therapeutics is advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Our patient-centric model of innovation leverages proven …See details»
Viridian Therapeutics - Crunchbase Company Profile
Viridian Therapeutics focuses in advancing new treatments for patients with diseases that are underserved by today’s therapies. View contacts for Viridian Therapeutics to access new leads and connect with decision-makers.See details»
miRagen Therapeutics Announces Company Name Change to …
Jan 19, 2021 · Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most …See details»
MiRagen Therapeutics Completes Acquisition of Viridian, Raises …
Oct 28, 2020 · MiRagen Therapeutics said it completed the acquisition of privately held Viridian Therapeutics and entered into a private placement agreement with a group of institutional …See details»
miRagen Therapeutics, Inc. Announces Acquisition of Viridian
Oct 28, 2020 · BOULDER, Colo. and WALTHAM, Mass., Oct. 28, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (“miRagen”) (NASDAQ: MGEN) today announced it has …See details»
Patient Community - Viridian Therapeutics, Inc.
Viridian is focused on engineering and developing potential best-in-class medicines for people living with autoimmune and rare diseases.See details»
Viridian Nutrition
Viridian Nutrition, home of the leading name in ethical nutrition and beauty. Award-winning range of vitamins, minerals, herbs, organics, beauty, nutritional oils, specialty supplements, tinctures …See details»
Viridian Therapeutics, Inc. Email Format | viridianbio.com Emails
Viridian Therapeutics, Inc. uses 2 email formats: 1. first [email protected] (50.0%). Enter a name to find & verify an email >>>See details»
Clinical Trials - Viridian Therapeutics, Inc.
Viridian Therapeutics is focused on engineering and developing potential best-in-class medicines for people living with autoimmune and rare diseases. Viridian is studying multiple candidates in …See details»
Exceptional traits among us | Variant Bio
Variant Bio is developing life-saving therapies by studying the genes of people with exceptional health-related traits. Drug development has become increasingly difficult due to high costs and …See details»
Biomanufacturing series: Vaccine and Infectious Disease …
Find out about the Vaccine and Infectious Disease Organization (VIDO)'s COVID-19 research and vaccine development and its new Good Manufacturing Practices (GMP) facility, which …See details»
Our Pipeline - Viridian Therapeutics, Inc.
We have created a robust pipeline of differentiated investigational therapeutic candidates for well-validated targets.See details»